Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
Study NCT ID:
NCT05134532
Status:
UNKNOWN
Last Update Posted:
2023-04-26
First Post:
2021-11-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
Sponsor:
CHA University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-02
First Submit QC Date:
None
Study First Post Date:
2021-11-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-25
Last Update Post Date:
2023-04-26
Last Update Post Date Type:
ACTUAL